Literature DB >> 2941491

Anti-staphylococcal activity of teicoplanin, vancomycin, and other antimicrobial agents: the significance of methicillin resistance.

V E Del Bene, J F John, J A Twitty, J W Lewis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2941491     DOI: 10.1093/infdis/154.2.349

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  16 in total

1.  In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873.

Authors:  F Biavasco; R Lupidi; P E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

2.  Constant rate infusion of vancomycin in premature neonates: a new dosage schedule.

Authors:  F Pawlotsky; A Thomas; M F Kergueris; T Debillon; J C Roze
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

3.  Species identification, antibiotic sensitivity and slime production of coagulase-negative staphylococci isolated from clinical specimens.

Authors:  M A Deighton; J C Franklin; W J Spicer; B Balkau
Journal:  Epidemiol Infect       Date:  1988-08       Impact factor: 2.451

Review 4.  Teicoplanin. A pharmacoeconomic evaluation of its use in the treatment of gram-positive infections.

Authors:  C M Spencer; H M Bryson
Journal:  Pharmacoeconomics       Date:  1995-04       Impact factor: 4.981

5.  Overproduction of a 37-kilodalton cytoplasmic protein homologous to NAD+-linked D-lactate dehydrogenase associated with vancomycin resistance in Staphylococcus aureus.

Authors:  W M Milewski; S Boyle-Vavra; B Moreira; C C Ebert; R S Daum
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

Review 6.  Coagulase-negative staphylococci.

Authors:  Karsten Becker; Christine Heilmann; Georg Peters
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

7.  Comparative in vitro activities of teicoplanin, vancomycin, oxacillin, and other antimicrobial agents against bacteremic isolates of gram-positive cocci.

Authors:  E A Gorzynski; D Amsterdam; T R Beam; C Rotstein
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

8.  Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options.

Authors:  Silvia Natoli; Carla Fontana; Marco Favaro; Alberto Bergamini; Gian Piero Testore; Silvia Minelli; Maria Cristina Bossa; Mauro Casapulla; Giorgia Broglio; Angela Beltrame; Laura Cudillo; Raffaella Cerretti; Francesca Leonardis
Journal:  BMC Infect Dis       Date:  2009-06-04       Impact factor: 3.090

9.  Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital.

Authors:  I Shalit; S A Berger; A Gorea; H Frimerman
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

10.  Molecular epidemiology of trimethoprim resistance among coagulase-negative staphylococci.

Authors:  D W Galetto; J L Johnston; G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.